- 3.4Impact Factor
- 9.9CiteScore
- 20 daysTime to First Decision
Vaccines, Volume 10, Issue 4
April 2022 - 150 articles
Cover Story: Seasonal influenza can cause severe morbidity, mortality, and financial burden in pediatric and adult populations. Before the COVID-19 pandemic, 15% to 45% of children were infected yearly with influenza viruses. The influenza vaccine (IV) is considered the most effective way to prevent influenza and influenza-related complications. Up to 2018, only 5 out of 30 EU/EEA member states offered seasonal IV to healthy children or adolescents free of charge. Due to the high burden of influenza and the low IV coverage in the pediatric population, this study aims to assess the effectiveness of the influenza vaccine in preventing influenza infection in a cohort of healthy children. Our findings showed high influenza vaccine effectiveness, as well as no additional or prolonged effects of the influenza vaccine, suggesting the importance of seasonal flu vaccination every year. View this paper.
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.
Get Alerted
Add your email address to receive forthcoming issues of this journal.
Vaccines - ISSN 2076-393X